Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-923-5 | CAS number: 4553-62-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral: LD50 male (rats) is 170 mg/kg bw. Therefore, the product is considered as Toxic by oral route according to EU criteria.
Dermal: LD50 male (rats) is 982 mg/kg bw. Therefore, the product is considered as Toxic by dermal route according to EU criteria.
Inhalation: LC50/4h male (rats) is 0.66 mg/L. Therefore the product is considered as Toxic by inhalation route according to EU criteria.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 170 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 660 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 982 mg/kg bw
Additional information
1- Acute toxicity: oral:
Three studies were available. Two of them were considered as not reliable (Kr: 3) and the study of Rondot, 1981 was identified as the key study (Kr: 2). This acute oral toxicity study was performed similarly to the OECD test guideline No. 401 and a groups of Sprague-Dawley rat (5/sex/group) were given a single oral dose of 2- Methylglutaronitrile (2-MGN) in aqueous suspension of 10% arabic gum at doses of 0, 150, 200, 250, 300 or 400 mg/kg bw and observed for 14 days. At all tested doses (males and females), the clinical signs observed were reduced activity, apathy, prostration, piloerection, trembling and convulsion. All these signs were reversible 24 hours after the treatment. Haemorrhagic digestive tract, thymus and lungs was observed in the animals died during the study. The body weight and weight gain were not affected.
Oral LD50male/female = 205 mg/kg bw
Oral LD50male = 170 mg/kg bw
Oral LD50female = 225 mg/kg bw
Based on these results, the oral LD50 males = 170 mg/kg bw was chosen considering as the worst case (males were more sensitive than females). Thus, 2-Methylglutaronitrile is considered as toxic if swallowed.
2- Acute toxicity: inhalation
Three studies were available for this point. Two of them were considered as not reliable (Kr: 3). Another study (Reinhardt, 1974) was chosen as a key study (Kr: 2). A groups of male ChR-CD rats (6 animals/dose) were exposed to vapors for 4 hours in a whole body method at the concentrations of vapors 0.33; 0.34; 0.49 and 1.1 mg/L. Severe convulsions, exophthalmos and cyanosis were followed by death immediately to one day post-exposure, when the animals were exposed to lethal dose. Inhalation LC50males = 0.66 mg/L. Thus, 2 -Methylglutaronitrile is considered as toxic by inhalation route.
3- Acute toxicity: dermal
Four studies were available. Two of them were considered as not reliable (Kr: 3). A study of Rondot, 1981 was identified as the key study. In this study, 2-Methylglutaronitrile was tested for acute dermal toxicity similarly to the OECD test guideline No. 402. Groups of Sprague-Dawley rats (5 or 10 animals/sex/group) were exposed to2-Methylglutaronitrileundiluted for 24 hours at doses of 0,1000, 1100, 1500 and 2000 mg/kg bw and observed for 14 days. At equivalent dose level, mortality was more pronounced in males than in females. Therefore the LD50 males was considered as the worst case and was the reference to propose the classification. Clinical signs include reduced activity, apathy, prostration, slight ptosis, slight trembling. The autopsy of animals died during the test revealed haemorrhagic lungs, pale and mottled liver, thickened peritoneum, hemorrhagic patch on the skin.
Dermal LD50males (rats) = 982 mg/kg bw.
A study of Dashiell, 1983 was considered as a supporting study (Kr: 2), the LD50/male rabbits = 776 mg/kg bw.
Based on the Dermal LD50males (rats) = 982 mg/kg bw and the LD50/rabbits = 776 mg/kg bw, 2-Methylglutaronitrile is considered as toxic in contact with skin.
Justification for classification or non-classification
2 -Methylglutaronitrile is not classified in the Annex VI of the CLP regulation (1272/2008). A self-classification is proposed as followed:
1- Acute oral toxicity:
Based on LD50 male rats = 170 mg/kg bw (the worst case, males were more sensitive than females), 2 -methylglutaronitrile is classified as:
- Category III, H301 (Toxic if swallowed) according to the CLP regulation (1272/2008)
- Toxic if swallowed (T, R25) according to the Directive 67/548/EEC.
2- Acute inhalation toxicity:
Based on LC50/ male rats/4h = 0.66 mg/L (95% confidence limits of 0.39 and 1.34 mg/L). 2 -methylglutaronitrile is classified as:
- Category II, H330 (Fatal if inhaled) according to the CLP regulation (1272/2008)
- Toxic by inhalation (T, R23) according to the Directive 67/548/EEC.
3- Acute dermal toxicity:
Based on LD50 male rats = 982 mg/kg bw (Key study, the worst case, males were more sensitive than females) and on LD50 male rabbits = 776 mg/kg bw (supporting study), 2 -methylglutaronitrile is classified as:
- Category III, H311 (Toxic in contact with skin) according to the CLP regulation
- Harmful in contact with skin (Xn, R21) according to the Directive 67/548/EEC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.